Hca Healthcare, INC Form 4 insider transactions

HCA Healthcare EVP and CFO Mike Marks transferred 3,336 shares of common stock to a family trust.

Director William R. Frist acquired 809 restricted share units as part of his annual director compensation package.

Director Thomas F. Frist III acquired 1,041 restricted share units as part of his annual director compensation package.

Director Andrea B. Smith was granted 509 restricted share units as part of HCA Healthcare's annual director equity compensation.

Director Wayne Joseph Riley acquired 509 restricted share units as part of an annual director equity award.

Director Michael W. Michelson received an equity grant of 925 restricted share units as part of his annual compensation.

Director Hugh F. Johnston acquired 809 restricted share units as part of his annual director compensation package.

Director Nancy-Ann DeParle received an annual equity grant of 509 restricted share units in HCA Healthcare, Inc.

Director John Chidsey acquired 809 shares of HCA Healthcare common stock via restricted share units as part of his annual director compensation.

HCA Healthcare's EVP & Chief Legal & Administrative Officer, Michael R. McAlevey, exercised stock appreciation rights and subsequently sold a portion of the acquired shares.

HCA Healthcare's SVP & Controller, Christopher F. Wyatt, reported the vesting of performance share units and subsequent sale of common stock.

HCA Healthcare's SVP & Chief Nurse Executive, Erica Rossitto, reported the vesting of performance share units and a subsequent sale for tax obligations.

HCA Healthcare's EVP & Chief Legal & Admin Officer, Michael R. McAlevey, acquired 8,372 shares of common stock following the vesting of performance share units, while also disposing of shares for tax purposes.

HCA Healthcare's EVP and CFO, Mike A. Marks, saw 5,026 performance share units vest at 200% of target due to strong 2023-2025 EPS performance.

HCA Healthcare CEO Samuel N. Hazen's performance share units, tied to 2023-2025 EPS goals, vested at 200% of the target.

HCA Healthcare's EVP and COO, Jon M Foster, saw 15,696 performance share units vest at 200% of target due to strong 2023-2025 EPS performance.

HCA Healthcare's EVP and Chief Clinical Officer, Michael S. Cuffe, saw 200% of his performance share units vest due to exceeding EPS goals.

HCA Healthcare's SVP & Chief Human Resources Officer, Jennifer Berres, reported the vesting of performance share units and subsequent sales of common stock.

Thomas F. Frist Jr., a Director and 10% owner of HCA Healthcare, reported a significant share reorganization involving Frisco Holding II.

HCA Healthcare Director William R. Frist reported a significant internal reorganization of his beneficial ownership in the company through related entities Frisco Holding II and Hercules Holding II.

HCA Healthcare Director and 10% Owner Thomas F. Frist III reported a significant internal share reorganization involving Frisco Holding II, exchanging 36.6 million shares for 36.5 million newly issued shares.

HCA Healthcare Director Patricia F. Elcan reported a significant internal reorganization of shares held by Frisco Holding II, involving the disposition and acquisition of tens of millions of common stock shares.

Hercules Holding II, a significant HCA Healthcare shareholder, distributed over 36 million shares to Frisco Holding II in an internal transfer.

Frisco Holding II, a 10% owner of HCA Healthcare, Inc., completed a share exchange as part of a corporate reorganization, maintaining its pecuniary interest.

HCA Healthcare's SVP & Controller, Christopher F. Wyatt, exercised stock appreciation rights and disposed of shares for tax purposes.

HCA Healthcare's EVP and COO, Jon M. Foster, exercised stock appreciation rights and subsequently sold shares to cover tax liabilities.

HCA Healthcare CEO Samuel N. Hazen reported the sale of over 42,000 shares and a trust transfer of 1,045 shares, all executed under a pre-arranged 10b5-1 trading plan.

HCA Healthcare's EVP and Chief Clinical Officer, Michael S. Cuffe, reported the sale of 1,500 shares and the gifting of 4,050 shares of common stock.

HCA Healthcare's SVP & Controller, Christopher F. Wyatt, was granted 2,560 Stock Appreciation Rights with a vesting schedule beginning in 2027.

HCA Healthcare's EVP & Chief Legal & Admin Officer, Michael R. McAlevey, was granted 8,067 stock appreciation rights with an exercise price of $482.53.